Matthew Plunkett's Net Worth
$1.97 Million
Who is Matthew Plunkett?
Matthew Plunkett has an estimated net worth of $1.97 Million. This is based on reported shares across multiple companies, which include Nkarta, Inc., Imago BioSciences, Inc., and CELL THERAPEUTICS INC.
SEC CIK
Matthew Plunkett's CIK is 0001557551
Past Insider Trading and Trends
2013 was Matthew Plunkett's most active year for acquiring shares with 3 total transactions. Matthew Plunkett's most active month to acquire stocks was the month of February. 2014 was Matthew Plunkett's most active year for disposing of shares, totalling 134 transactions. Matthew Plunkett's most active month to dispose stocks was the month of August. 2015 saw Matthew Plunkett paying a total of $0.00 for 2,028,994 shares, this is the most they've acquired in one year. In 2014 Matthew Plunkett cashed out on 384,936 shares for a total of $1,186,296.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nkarta, Inc. (NKTX) Snapshot price: $5.2
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Imago BioSciences, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELL THERAPEUTICS INC No price found
EVP, Chief Business OfficerMatthew Plunkett owns 526,210 units of Common Stock. In the year 2012 Matthew Plunkett filed a total of 38 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -10.82% | -63.87K |
$0.55 | -$35,015.73 | 526.21K |
Mar 21
| |||
Form 4
| -1.67% | -10.00K |
$0.59 | -$5,904.05 | 590.08K |
Scheduled
|
Mar 4
| ||
Form 4
| -1.64% | -10.00K |
$1.15 | -$11,538.50 | 600.08K |
Scheduled
|
Feb 4
| ||
Form 4
| -1.61% | -10.00K |
$1.21 | -$12,133.58 | 610.08K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
| -1.59% | -10.00K |
$1.00 | -$9,968.61 | 620.08K |
Scheduled
|
Dec 4
| ||
Form 4
| -1.56% | -10.00K |
$1.38 | -$13,813.50 | 630.08K |
Scheduled
|
Nov 4
| ||
Form 4
| -1.54% | -10.00K |
$1.52 | -$15,204.34 | 640.08K |
Scheduled
|
Oct 5
| ||
Form 4
| -10.34% | -75.00K |
$1.41 | -$106,051.67 | 650.08K |
Sep 29
| |||
Form 4
| -9.47% | -75.87K |
$1.57 | -$119,040.50 | 725.08K |
Scheduled
|
Sep 24
| ||
Form 4
| +23.37% | 151.74K |
—
|
—
| 800.95K |
Sep 21
| |||
Form 4
| -3.35% | -22.53K |
$1.53 | -$34,394.02 | 649.21K |
Scheduled
|
Sep 4
| ||
Form 4
| -1.47% | -10.00K |
$1.84 | -$18,426.00 | 671.74K |
Scheduled
|
Aug 4
| ||
Form 4
| -1.45% | -10.00K |
$1.95 | -$19,493.08 | 681.74K |
Scheduled
|
Jul 6
| ||
Form 4
| -1.43% | -10.00K |
$2.06 | -$20,612.50 | 691.74K |
Scheduled
|
Jun 4
| ||
Form 4
| -1.41% | -10.00K |
$1.86 | -$18,552.50 | 701.74K |
Scheduled
|
May 4
| ||
Form 4
| -2.27% | -16.57K |
$1.88 | -$31,182.37 | 711.74K |
Scheduled
|
Apr 6
| ||
Form 4
| -14.04% | -118.91K |
$1.95 | -$231,711.50 | 728.31K |
Scheduled
|
Mar 21 - Mar 23
| ||
Form 4
| -1.40% | -12.00K |
$2.41 | -$28,939.00 | 847.22K |
Scheduled
|
Mar 4
| ||
Form 4
| -1.38% | -12.00K |
$2.22 | -$26,651.00 | 859.22K |
Scheduled
|
Feb 4
| ||
Form 4
| +121.14% | 477.25K |
—
|
—
| 871.22K |
Jan 8
| |||
Form 4
| -2.96% | -12.00K |
$2.36 | -$28,364.50 | 393.97K |
Scheduled
|
Jan 5
| ||
Form 4
| -2.87% | -12.00K |
$2.23 | -$26,807.50 | 405.97K |
Scheduled
|
Dec 4
| ||
Form 4
| -2.79% | -12.00K |
$2.39 | -$28,664.70 | 417.97K |
Scheduled
|
Nov 4
| ||
Form 4
| -2.72% | -12.00K |
$2.39 | -$28,732.88 | 429.97K |
Scheduled
|
Oct 6
| ||
Form 4
| -18.99% | -103.64K |
$2.56 | -$264,917.51 | 441.97K |
Scheduled
|
Sep 22 - Sep 23
| ||
Form 4
| -4.77% | -27.30K |
$2.48 | -$67,616.88 | 545.6K |
Scheduled
|
Sep 4
| ||
Form 4
| -2.05% | -12.00K |
$2.48 | -$29,722.00 | 572.9K |
Scheduled
|
Aug 4
| ||
Form 4
| -2.01% | -12.00K |
$2.89 | -$34,698.50 | 584.9K |
Scheduled
|
Jul 7
| ||
Form 4
| -1.97% | -12.00K |
$3.02 | -$36,255.56 | 596.9K |
Scheduled
|
Jun 4
| ||
Form 4
| -1.93% | -12.00K |
$2.96 | -$35,496.78 | 608.9K |
Scheduled
|
May 5
| ||
Form 4
| -21.49% | -170.00K |
$3.73 | -$633,383.94 | 620.9K |
Mar 21
| |||
Form 4
| +99.37% | 394.2K |
—
|
—
| 790.9K |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| +296.71% | 296.7K |
—
|
—
| 396.7K |
Mar 21
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||